| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
| Targets |
Regaloside F's molecular targets are not well-characterized. As a phenolic glycerol glucoside found in lily bulbs, it may have antioxidant or other biological activities typical of phenolic compounds. The compound is classified under "Others" for its target category, indicating that specific molecular targets have not been identified. Further studies are needed to elucidate its mechanism of action and potential biological activities.
|
|---|---|
| ln Vitro |
In vitro activity data for Regaloside F are limited in the published literature. The compound has been primarily characterized as a phenolic glycerol glucoside from lily bulbs. As a phenolic compound, it may exhibit antioxidant activity. However, detailed in vitro activity data including IC₅₀ values are not extensively published. Further studies are needed to characterize its biological activities and potential therapeutic applications.
|
| ln Vivo |
In vivo activity data for Regaloside F are not available in the published literature. The compound has been primarily characterized as a natural product from lily bulbs. No in vivo pharmacological studies have been reported for this compound. Further research is needed to evaluate its potential biological activities in animal models. The compound's natural occurrence in edible lily bulbs suggests it may have nutritional or health-promoting properties.
|
| Enzyme Assay |
In vitro assays for Regaloside F are not extensively documented. As a phenolic compound, potential assays could include antioxidant activity evaluation using DPPH or ABTS radical scavenging assays. The compound's structure can be confirmed by NMR and MS. Purity is typically assessed by HPLC with purity ≥98%. Standard phenolic compound characterization methods may be applied.
|
| Cell Assay |
In vitro cellular assays for Regaloside F are not extensively documented. As a phenolic glycerol glucoside, potential cellular assays could include evaluation of antioxidant activity in cell-based oxidative stress models or cytoprotective effects. Cells are treated with the compound and exposed to oxidative insults, and cell viability is assessed using MTT or similar assays. The compound is stored at -20°C.
|
| Animal Protocol |
In vivo animal experiments for Regaloside F have not been reported in the published literature. The compound has been studied primarily as a natural product from lily bulbs. No animal studies have been conducted to evaluate its pharmacological effects, toxicity, or pharmacokinetics. Further research would be required to investigate its potential therapeutic applications in vivo.
|
| ADME/Pharmacokinetics |
Pharmacokinetic properties of Regaloside F have not been characterized. The compound has a molecular weight of 430.40 g/mol and molecular formula C₁₉H₂₆O₁₁. As a glycosylated phenolic compound, it is expected to have limited oral bioavailability due to its hydrophilic sugar moiety. The compound may undergo deglycosylation in the gastrointestinal tract. Storage: -20°C.
|
| Toxicity/Toxicokinetics |
The toxicological profile of Regaloside F is not extensively documented. As a phenolic glycerol glucoside found in edible lily bulbs, it is expected to have a relatively favorable safety profile. However, comprehensive toxicological evaluations including acute toxicity, genotoxicity, and repeated-dose studies have not been reported. Standard laboratory safety precautions should be followed when handling this compound.
|
| References | |
| Additional Infomation |
Regaloside F has been reported in Lily and Lily, and data are available.
Regaloside F (CAS# 120601-65-2, molecular formula C₁₉H₂₆O₁₁, molecular weight 430.40) is a phenolic glycerol glucoside found in lily bulbs. Also known as 王百合苷F. No clinical trials or regulatory approvals have been identified. Storage: -20°C. Purity: ≥98%. |
| Molecular Formula |
C19H26O11
|
|---|---|
| Molecular Weight |
430.40300
|
| Exact Mass |
430.148
|
| CAS # |
120601-65-2
|
| PubChem CID |
14284479
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.50±0.1 g/cm3(Predicted)
|
| Boiling Point |
741.5±60.0 °C(Predicted)
|
| LogP |
-1.1
|
| Hydrogen Bond Donor Count |
6
|
| Hydrogen Bond Acceptor Count |
11
|
| Rotatable Bond Count |
10
|
| Heavy Atom Count |
30
|
| Complexity |
557
|
| Defined Atom Stereocenter Count |
6
|
| SMILES |
OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC[C@H](O)COC(/C=C/C2=CC(OC)=C(O)C=C2)=O)O1
|
| InChi Key |
ZGENOXMVMATRDW-FSTLHUPISA-N
|
| InChi Code |
InChI=1S/C19H26O11/c1-27-13-6-10(2-4-12(13)22)3-5-15(23)28-8-11(21)9-29-19-18(26)17(25)16(24)14(7-20)30-19/h2-6,11,14,16-22,24-26H,7-9H2,1H3/b5-3+/t11-,14-,16-,17+,18-,19-/m1/s1
|
| Chemical Name |
[(2S)-2-hydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3234 mL | 11.6171 mL | 23.2342 mL | |
| 5 mM | 0.4647 mL | 2.3234 mL | 4.6468 mL | |
| 10 mM | 0.2323 mL | 1.1617 mL | 2.3234 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
